Medicome Sp. z o.o.

At Medicome Sp. z o.o. in Oświęcim, clinical trials in cardiovascular diseases focus on conditions such as atrial fibrillation, acute coronary syndrome, myocardial infarction, heart failure, and hypertension. These studies are designed to test new treatment options, improve risk reduction, and better understand how to protect patients from major heart and circulation complications.

• Studies are evaluating strategies for atrial fibrillation to help prevent stroke and other embolic events.
• Research in heart failure and post-myocardial infarction care is exploring ways to improve outcomes and reduce future cardiac events.
• Trials in arterial hypertension and broader cardiovascular disease are assessing better control of blood pressure and long-term protection.

Overall, this site is contributing to research that aims to make cardiovascular care more effective, safer, and more personalized.

A major part of the trial portfolio at this hospital/clinic centers on digestive system diseases, especially Crohn’s disease and ulcerative colitis. The studies are mainly focused on testing new therapies, maintaining remission, and improving symptom control for people living with chronic intestinal inflammation.

• Research in Crohn’s disease is examining treatments intended to reduce inflammation and support clinical remission.
• Multiple ulcerative colitis studies are looking at long-term safety, symptom improvement, and sustained disease control.
• Additional work in digestive system diseases includes erosive esophagitis related to GERD, with the goal of improving healing and maintenance of recovery.

This research area reflects a strong interest in advancing care for chronic gastrointestinal conditions that can significantly affect daily life.

Trials in nutritional and metabolic diseases at Medicome Sp. z o.o. include obesity, overweight, mixed dyslipidemia, and related cardiometabolic conditions. These studies are aimed at evaluating new approaches to weight management, lipid control, and broader metabolic risk reduction.

• Studies in obesity and overweight are testing therapies intended to support meaningful weight reduction.
• Research on mixed dyslipidemia is focused on improving lipid levels and lowering cardiovascular risk.
• Some trials combine metabolic disease and cardiovascular disease research to address overlapping health risks more effectively.

This area highlights a growing effort to manage conditions that often occur together and contribute to long-term heart and metabolic complications.

The site also supports research in immune system diseases and skin and connective tissue diseases, with studies in chronic spontaneous urticaria, chronic inducible urticaria, and related allergic skin disorders. These trials are exploring new ways to reduce itching, hives, and other symptoms that can strongly affect comfort and quality of life.

• Trials in chronic spontaneous urticaria are assessing treatments designed to better control persistent hives.
• Research in chronic inducible urticaria, including cold-triggered forms, is evaluating symptom relief and provocation response.
• This area of immune-mediated disease research aims to improve daily symptom management and treatment effectiveness.

The focus here is on helping patients achieve more stable control of recurring allergic and inflammatory skin conditions.

Clinical trials at the site span several additional therapeutic areas, including respiratory tract diseases, nervous system diseases, and otorhinolaryngologic diseases. The research includes asthma, chronic obstructive pulmonary disease, respiratory tract infections, early Alzheimer’s disease, and conditions affecting the upper airway and related structures. The purpose is to test new options for symptom control, prevention, and disease management.

• Studies in respiratory tract diseases are examining ways to reduce infections and improve care for chronic breathing disorders.
• Research in early Alzheimer’s disease is looking at whether new approaches can support cognition and slow decline.
• Work in otorhinolaryngologic diseases adds another dimension to the site’s broad clinical research portfolio.

Together, these trials show a wide-ranging effort to address both common chronic illnesses and conditions with important long-term health consequences.